10月30日 - ** 制药公司百健BIIB.O股价盘前下跌4%至142美元
** 百健下调年度利润预期 (link) 预计第四季度某些与收购相关的支出将导致每股利润下降1.25美元
** 该公司 预计 2025 年调整后每股利润介于 14.50 美元至 15.00 美元之间，而之前的预期介于 15.50 美元至 16.00 美元之间。
** BIIB 公布第三季度 每股收益为 4.81 美元，分析师平均预期为每股收益 3.88 美元 - LSEG 数据
** 截至收盘，股价累计下跌3.1%。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.